Related Experiment Videos

Pulmonary apical fibrocystic disease. A serologic study

European Journal of Respiratory Diseases
|February 1, 1981
PubMed

Insights

This study investigated 12 patients with progressive pulmonary fibrocystic changes, excluding tuberculosis. No uniform cause was found, but slow-acting viral or fungal infections are suggested as potential factors.

Area of Science:

  • Pulmonary Medicine
  • Immunology
  • Infectious Diseases

Background:

  • Progressive pulmonary apical fibrocystic changes present a diagnostic challenge.
  • Exclusion of active tuberculosis is crucial in differential diagnosis.

Purpose of the Study:

  • To identify common aetiopathogenic factors in patients with progressive pulmonary apical fibrocystic changes.
  • To explore potential autoimmune, infectious, or genetic links.

Main Methods:

  • Human leukocyte antigen (HLA) typing was performed.
  • Analysis of various antibodies including tissue, antimicrobial, influenza, and smooth muscle antibodies.
  • Assessment of serum proteins, immunoglobulins, rheumatoid factor, and C-reactive protein.

Main Results:

  • No clear HLA trends were observed, except for HLA-B27 positivity in patients with spondylitis.
  • Autoimmune markers and most antimicrobial antibodies were negative.
  • All patients had low-titred influenza antibodies; nine showed low positive smooth muscle antibodies.
  • Biochemical markers indicated chronic inflammation.

Conclusions:

  • No single aetiopathogenic factor was identified for the observed pulmonary fibrocystic changes.
  • The findings suggest a possible role for unidentified slow-acting viral or fungal infections.
  • Further research is warranted to elucidate the etiology of this condition.

Related Concept Videos